FLT1 anticorps (Biotin)
Aperçu rapide pour FLT1 anticorps (Biotin) (ABIN1589687)
Antigène
Voir toutes FLT1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- VEGFR-1/Flt-1 antibody
-
Specificité
- Recombinant human soluble Flt-1(D1-5)
-
Attributs du produit
- Produced from sera of rabbits immunised with highly pure recombinant human soluble extracellular domain of Flt-1/VEGFR-1 (110 kDa) as the immunizing antigen.
-
Purification
- Anti-human VEGFR-1/Flt-1 was purified by antigen-affinity chromatography with immobilised recombinant soluble VEGFR-1/VEGFR-1 or by protein A chromatography.
-
Immunogène
- Recombinant human soluble Flt-1(D1-5)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- ELISA: Use 2-5 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
-
Buffer
- PBS, BSA (50x), 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Centrifuge vial prior to opening.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
-
Date de péremption
- 24 months
-
-
- FLT1 (Fms-Related tyrosine Kinase 1 (VEGFR1) (FLT1))
-
Autre désignation
- VEGFR-1/Flt-1
-
Sujet
- Vascular endothelial growth factor receptor-1, FLT1, VEGF receptor 1,Endothelial cells express three different vascular endothelial growth factor (VEGF) receptors, belonging to the family of receptor tyrosine kinases (RTKs). They are named VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1), VEGFR-3 (Flt-4). Their expression is almost exclusively restricted to endothelial cells, but VEGFR-1 can also be found on monocytes, dendritic cells and on trophoblast cells. The flt-1 gene was first described in 1990. The receptor contains seven immunoglobulin-like extracellular domains, a single transmembrane region and an intracellular splited tyrosine kinase domain. Compared to VEGFR-2 the Flt-1 receptor has a higher affinity for VEGF but a weaker signaling activity. VEGFR-1 thus leads not to proliferation of endothelial cells, but mediates signals for differentiation. Interestingly a naturally occuring soluble variant of VEGFR-1 (sVEGFR-1) was found in HUVEC supernatants in 1996, which is generated by alternative splicing of the flt-1 mRNA.
-
ID gène
- 2321
-
NCBI Accession
- NM_001159920, NP_001153392
-
UniProt
- P17948
-
Pathways
- Signalisation RTK, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Antigène
-